Navigation Links
Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress

BASEL, Switzerland, May 21, 2007 - Results from phase III clinical trials and further human pharmacology studies were presented at the 16th Congress of the European Academy of Dermatology and Venereology (EADV). These data highlighted the efficacy and safety profile of alitretinoin as a potential once daily oral treatment for patients with severe refractory chronic hand eczema.

Currently, no approved treatment exists for severe Chronic Hand Eczema (CHE) refractory or unresponsive to topical therapy. This debilitating disease can cause significant pain and functional impairment of the hands as well as considerable psychological, social and occupational impact on patients' lives. The data presented at this meeting will form part of the regulatory submissions later this year and show the potential for alitretinoin to become the first product available to treat an estimated one million patients in North America and Europe.

Eight posters on alitretinoin presented in the main conference and four oral presentations in a company sponsored satellite symposium highlighted alitretinoin as a potential treatment for severe refractory CHE.

Positive efficacy and safety data on alitretinoin were reported in posters from the pivotal BACH trial (poster number 275), the re-treatment study (280) and an open-label safety study (281). Five further posters covered aspects of the pharmacology of alitretinoin (286, 287, 288, 289 and 290).

Previously reported results for the phase III BACH study (275) confirm the efficacy and tolerability of oral alitretinoin for the treatment of CHE in patients refractory to topical corticosteroids. Once daily alitretinoin resulted in response of 48% of the patients who were treated with 30mg per day for up to six months. Response rate and time to response were dose dependent with a faster response seen with the higher dose. Alitretinoin was generally well tolerated in these
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
6. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
7. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
8. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
9. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
10. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
11. Studies Show Efficacy and Safety of Alexions Soliris in Broad Population of PNH Patients
Post Your Comments:
(Date:5/26/2015)... May 26, 2015  AbbVie (NYSE: ABBV ... GIFT-I study of its investigational, all-oral, interferon (IFN)- ... ombitasvir/paritaprevir/ritonavir at the Annual Meeting of the Japan ... . 1 GIFT-I evaluated genotype 1b ... patients, with and without cirrhosis, who were either ...
(Date:5/26/2015)... BRAINTREE, Mass. , May 26, 2015  Haemonetics ... Gerry Gould , Vice President, Investor Relations, will present ... Boston on June 4 th , ... public may access Mr. Gould,s presentation live via webcast ... Haemonetics (NYSE: HAE ) is a global ...
(Date:5/26/2015)... , May 26, 2015  XRpro Sciences, Inc., a ... services which features high throughput transporter and ion channel assays ... present at the 2015 Marcum MicroCap Conference on ... at the Grand Hyatt Hotel. The ... Timothy Tyson , Chairman is scheduled to begin at 1:30 ...
Breaking Medicine Technology:AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6XRpro Sciences, Inc. To Present at 2015 Marcum MicroCap Conference 2
... human-animal hybrids to generate stem cells WORCESTER, Mass., ... Sheets: ACTC) and its collaborators reported today that human ... adult human cells. The research, which appears online ahead ... Cells (Editor-in-Chief: Sir Ian Wilmut; published by Mary ...
... Robert C. Gallo Foundation for AIDS and Virus ... as director of international relations. The foundation ... internationally known for expertise in HIV prevention, treatment ... producing groundbreaking HIV research."It is an honor to ...
Cached Medicine Technology:Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research 2
(Date:5/27/2015)... The Case Management Society of America ... CMSA Lifetime Achievement Award, to Anne Llewellyn RN-BC, MS, ... 25th at the association’s 25th Annual Conference and Expo ... The CMSA Board of Directors awards the Lifetime Achievement ... significant contribution to practice of case management and in ...
(Date:5/27/2015)... May 27, 2015 Water, ... water filtration products, has announced that its elite ... of the first to pass the new NSF/ANSI ... certification is monumental, proving that the BG-12000 by ... pharmaceuticals, over-the-counter medications, and chemicals used in manufacturing ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 One of ... an upcoming episode of “In America” that takes a ... condition is best described as an abnormal heart rhythm. ... that beats either irregularly or much too quickly. , ... atrial fibrillation develops in an effort to inform viewers ...
(Date:5/27/2015)... 2015 HomeTown Health, along with other ... Georgia cities on May 13 & 14. In each ... to meet with the group of representatives and receive ... office staff attended. , Referred to as the ... bring together Health Information Technology and ICD-10 resources with ...
(Date:5/26/2015)... May 27, 2015 In celebration of Parker ... is offering a discount on HVAC systems with a high ... , HVAC systems with a SEER rating around 15-16 ... as $20/month. For those unfamiliar with a SEER rating, it ... More specifically, it measures the amount of energy expended by ...
Breaking Medicine News(10 mins):Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 3Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 2Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 3Health News:Parker and Sons Recounts its Path to Success 2
... in getting married and more involvements in serious family relationships ... male psychology. // ,About 12,000 men and women, ... regarding sex, living together, marriage, divorce and parenting by the ... first agency study involving men since 1973. ,Nearly ...
... of Virginia Commonwealth University Massey Cancer Center have discovered ... small molecules containing platinum, which causes HIV and cancer. ... the researchers to develop new drugs to fight HIV ... fingers. ,In the May 30 issue of ...
... summer, mosquitoes too are out to suck warm blood. Apart ... lethal injection of many harmful diseases//. ,The program-in-charge ... an ambient atmosphere for mosquito to breed. In his words,' ... the United States in human population density and we're in ...
... A new research has shown promising development for women in ... researchers state that for women over 35 years undergoing IVF ... their chances of conception. They also state that the rates ... cut down. ,The researchers from Finland found that ...
... study conducted by the researchers at the Hamburg Outstation ... Max Planck Institute for //Infection Biology (MPIIB) has found ... TB bacteria to survive which could be targeted by ... deadliest and the oldest disease. It is caused by ...
... general belief that every thing in the US of ... to a report by an independent environmental organisation Sierra ... Americans get unsafe drinking water. They attribute it to ... Act protections from headwater and seasonal streams. ...
Cached Medicine News:Health News:New Research May Be Useful for Developing Drugs for HIV and Cancer 2Health News:Research Shows That Quality Not Age As The Most Important Factor In IVF 2Health News:Drinking water in America not all that safe: says report 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: